results of retrospective observational study of adalimumab safety and efficacy in patients with juvenile arthritis and uveitis

Clicks: 306
ID: 212098
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #7 of 111 articles by views in Biocontrol science

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

The article contains results of retrospective observational study of adalimumab safety and efficacy in 67 juvenile arthritis and juvenile arthritis with eye involvement patients refractory to classical immunosuppressive treatment. It also contains a description of a recombinant biological medication — adalimumab: already on the 4th week of treatment acute inflammatory changes in the affected joints were relieved, joint motion range fully recovered; by the week 8 — full remission of the uveitis was reported in 45% of affected eyes (27/61), normalized disease activity lab parameters such as ESR, serum C-reactive protein.

Key words: children, juvenile rheumatoid arthritis, rheumatoid uveitis, adalimumab.
(Voprosy sovremennoi pediatrii — Current Pediatrics. — 2011; 10 (6): 96–102)

Reference Key
alexeeva2011voprosyresults Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Е.I. Alexeeva;Е.V. Mitenko;Т.М. Bzarova;S.I. Valieva;А.М. Chomakhidze;K.B. Isaeva;Е.G. Chistyakova;R.V. Denisova;T.V. Sleptsova;Т.Yu. Polyaeva;А.N. Fetisova
Journal Biocontrol science
Year 2011
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.